Skip to main content
. Author manuscript; available in PMC: 2017 Sep 21.
Published in final edited form as: Clin Pediatr (Phila). 2016 Jul 19;56(1):65–70. doi: 10.1177/0009922816638664

Table 1.

Population Characteristics of Infants Receiving Antibiotic Prophylaxis.a

No BUTI
(n=571)
BUTI
(n=60)
p
Female 169 (30) 12 (20) 0.13
Gestational age, weeks
  ≤25 181 (32) 16 (27) 0.69
  26–28 201 (37) 20 (33)
  29–32 101 (18) 12 (20)
  33–36 44 (8) 7 (12)
  ≥37 35 (6) 5 (8)
Birth weight, g
  <1000 330 (58) 36 (60) 0.12
  1000–1499 134 (23) 7 (12)
  1500–2499 70 (12) 10 (17)
  2500–3499 31 (5) 5 (8)
  ≥3500 6 (1) 2 (3)
Race/ethnicity
  White 258 (46) 17 (29) 0.07
  Black 117 (21) 18 (31)
  Hispanic 152 (27) 21 (36)
  Other 30 (5) 3 (5)
Admission type
  Inborn 413 (74) 45 (78) 0.57
Postnatal age at initiation of
prophylaxis, days
  0–30 151 (13) 11 (7) 0.002
  31–60 375 (32) 32 (22)
  >60 652 (55) 104 (71)
a

Data are presented as n(%).

BUTI: breakthrough urinary tract infection.